These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 33961120)
1. Pheochromocytoma and Paraganglioma in Pregnancy: a New Era. Gruber LM; Young WF; Bancos I Curr Cardiol Rep; 2021 May; 23(6):60. PubMed ID: 33961120 [TBL] [Abstract][Full Text] [Related]
3. Intrarenal hemodynamics and kidney function in pheochromocytoma and paraganglioma before and after surgical treatment. Januszewicz M; Dobrowolski P; Januszewicz A; Warchoł-Celińska E; Jóźwik-Plebanek K; Motyl D; Kabat M; Pęczkowska M; Michałowska I; Ambroziak U; Toutounchi S; Gałązka Z; Courcelles L; Pappaccogli M; Eisenhofer G; Persu A; Lenders JWM; Kądziela J; Prejbisz A Blood Press; 2021 Jun; 30(3):172-179. PubMed ID: 33586556 [TBL] [Abstract][Full Text] [Related]
4. Maternal and fetal outcomes in phaeochromocytoma and pregnancy: a multicentre retrospective cohort study and systematic review of literature. Bancos I; Atkinson E; Eng C; Young WF; Neumann HPH; Lancet Diabetes Endocrinol; 2021 Jan; 9(1):13-21. PubMed ID: 33248478 [TBL] [Abstract][Full Text] [Related]
5. The diagnosis and management of pheochromocytoma and paraganglioma during pregnancy. Clifton-Bligh RJ Rev Endocr Metab Disord; 2023 Feb; 24(1):49-56. PubMed ID: 36637675 [TBL] [Abstract][Full Text] [Related]
6. Approach to the Patient: Perioperative Management of the Patient with Pheochromocytoma or Sympathetic Paraganglioma. Berends AMA; Kerstens MN; Lenders JWM; Timmers HJLM J Clin Endocrinol Metab; 2020 Sep; 105(9):. PubMed ID: 32726444 [TBL] [Abstract][Full Text] [Related]
7. [Clinical profile of pheochromocytoma and paraganglioma with normal plasma free metanephrines]. Liu L; Tian J; Wu K; Gao Y; Zhang Z; Zhang JQ; Guo XH Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 52(4):614-620. PubMed ID: 32773788 [TBL] [Abstract][Full Text] [Related]
8. Clinical Presentation and Treatment Outcomes of Children and Adolescents With Pheochromocytoma and Paraganglioma in a Single Center in Korea. Park H; Kim MS; Lee J; Kim JH; Jeong BC; Lee S; Lee SK; Cho SY; Jin DK Front Endocrinol (Lausanne); 2020; 11():610746. PubMed ID: 33584544 [TBL] [Abstract][Full Text] [Related]
9. Pathophysiology and Management of Glycemic Alterations before and after Surgery for Pheochromocytoma and Paraganglioma. Lopez C; Bima C; Bollati M; Bioletto F; Procopio M; Arata S; Candela DG; Beccuti G; Ghigo E; Maccario M; Parasiliti-Caprino M Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982228 [TBL] [Abstract][Full Text] [Related]
10. Cardiac Changes and Their Reversal Following Curative Surgery in Pheochromocytoma: PheoCard Prospective Cohort Study. Vishvak Chanthar KMM; Khanna R; Agarwal G; Rout SR; Kapoor A; Sabaretnam M; Chand G; Mishra A; Agarwal A; Mishra SK World J Surg; 2023 Feb; 47(2):304-311. PubMed ID: 36210362 [TBL] [Abstract][Full Text] [Related]
11. Influence of duration of preoperative treatment with phenoxybenzamine and secretory phenotypes on perioperative hemodynamics and postoperative outcomes in pheochromocytoma and paraganglioma. Yao Y; Guo Y; Fan J; Lin T; Wang L; Zhang S Front Endocrinol (Lausanne); 2023; 14():1139015. PubMed ID: 37152936 [TBL] [Abstract][Full Text] [Related]
12. The Role for Metyrosine in the Treatment of Patients With Pheochromocytoma and Paraganglioma. Gruber LM; Jasim S; Ducharme-Smith A; Weingarten T; Young WF; Bancos I J Clin Endocrinol Metab; 2021 May; 106(6):e2393-e2401. PubMed ID: 33693908 [TBL] [Abstract][Full Text] [Related]
13. Surgical Treatment of Malignant Pheochromocytoma and Paraganglioma: Retrospective Case Series. Strajina V; Dy BM; Farley DR; Richards ML; McKenzie TJ; Bible KC; Que FG; Nagorney DM; Young WF; Thompson GB Ann Surg Oncol; 2017 Jun; 24(6):1546-1550. PubMed ID: 28058556 [TBL] [Abstract][Full Text] [Related]
14. Pheochromocytoma and paraganglioma with negative results for urinary metanephrines show higher risks for metastatic diseases. Kawashima A; Sone M; Inagaki N; Okamoto K; Tsuiki M; Izawa S; Otsuki M; Okamura S; Ichijo T; Katabami T; Takeda Y; Yoshimoto T; Naruse M; Tanabe A Endocrine; 2021 Oct; 74(1):155-162. PubMed ID: 34272648 [TBL] [Abstract][Full Text] [Related]
15. Hypertension and cardiac damage in pheochromocytoma and paraganglioma patients: a large-scale single-center cohort study. Yu Y; Chen C; Meng L; Han W; Zhang Y; Zhang Z; Yang Y BMC Cardiovasc Disord; 2024 Jun; 24(1):325. PubMed ID: 38926862 [TBL] [Abstract][Full Text] [Related]
16. Controversies about the systematic preoperative pharmacological treatment before pheochromocytoma or paraganglioma surgery. Castinetti F; De Freminville JB; Guerin C; Cornu E; Sarlon G; Amar L Eur J Endocrinol; 2022 Mar; 186(5):D17-D24. PubMed ID: 35230260 [TBL] [Abstract][Full Text] [Related]
17. Current and future anatomical and functional imaging approaches to pheochromocytoma and paraganglioma. Timmers HJ; Taieb D; Pacak K Horm Metab Res; 2012 May; 44(5):367-72. PubMed ID: 22399235 [TBL] [Abstract][Full Text] [Related]
18. Preoperative Management of Pheochromocytoma and Paraganglioma. Fang F; Ding L; He Q; Liu M Front Endocrinol (Lausanne); 2020; 11():586795. PubMed ID: 33117294 [TBL] [Abstract][Full Text] [Related]
19. Impact of body composition and genotype on haemodynamics during surgery for pheochromocytoma and paraganglioma. Pang Y; Li M; Jiang J; Chen X; Fu Y; Wang C; He Y; Zhao Y; Wang Y; Guan X; Zhang L; Xu X; Gan Y; Liu Y; Xie Y; Tang T; Wang J; Xie B; Liang Z; Chen D; Liu H; Chen C; Eisenhofer G; Liu L; Yi X; Chen BT J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2843-2853. PubMed ID: 36068986 [TBL] [Abstract][Full Text] [Related]
20. Treatment and outcomes in pheochromocytomas and paragangliomas: a study of 110 cases from a single center. Falhammar H; Kjellman M; Calissendorff J Endocrine; 2018 Dec; 62(3):566-575. PubMed ID: 30220006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]